Hobden Adrian N

Avg. Two Year Performance

(25%) Avg. Purchase Return
(12%) Compound
29% Avg. Sale Return
14% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return15%(10%)(12%)(11%)(25%)
Purchase Success Rate1 of 10 of 10 of 10 of 10 of 1
Average Sale Return1%6%4%21%29%
Sale Success Rate4 of 107 of 104 of 106 of 105 of 10
Drugs » Drug Manufacturers - Major

President and CEO, Director:

Holdings: 208.37K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Diagnostic Substances

Pres. Myriad Pharmaceuticals:

Holdings: 234.07K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--